Xiaofei Li

916 total citations
46 papers, 611 citations indexed

About

Xiaofei Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofei Li has authored 46 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 21 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofei Li's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (10 papers) and MicroRNA in disease regulation (7 papers). Xiaofei Li is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (10 papers) and MicroRNA in disease regulation (7 papers). Xiaofei Li collaborates with scholars based in China, United States and Canada. Xiaofei Li's co-authors include Shujia Chen, Lingyan Xu, Lianyi Guo, Ying‐Hui Zhu, Yuqiao Li, Bing Dai, Sixian Chen, Wenjie Guo, Wei Tan and Haotian Xu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Xiaofei Li

44 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Li China 13 424 252 120 99 82 46 611
Chaoyue Su China 12 446 1.1× 234 0.9× 157 1.3× 74 0.7× 88 1.1× 14 636
Mingdong Lu China 15 463 1.1× 245 1.0× 146 1.2× 131 1.3× 47 0.6× 41 719
Zhifeng Ning China 14 379 0.9× 138 0.5× 174 1.4× 80 0.8× 84 1.0× 18 569
Huayi Li China 13 384 0.9× 165 0.7× 86 0.7× 84 0.8× 52 0.6× 17 546
Jingyuan Sun China 13 536 1.3× 296 1.2× 180 1.5× 84 0.8× 114 1.4× 26 896
Yang Cheng China 13 343 0.8× 194 0.8× 142 1.2× 93 0.9× 144 1.8× 25 621
Chiara Ciardiello Italy 11 616 1.5× 300 1.2× 137 1.1× 97 1.0× 88 1.1× 14 773
Mohsen Karami Fath Iran 12 338 0.8× 159 0.6× 105 0.9× 41 0.4× 61 0.7× 28 496
Qinghui Zheng China 11 394 0.9× 198 0.8× 175 1.5× 74 0.7× 62 0.8× 22 556

Countries citing papers authored by Xiaofei Li

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Li more than expected).

Fields of papers citing papers by Xiaofei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Li. The network helps show where Xiaofei Li may publish in the future.

Co-authorship network of co-authors of Xiaofei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Li. A scholar is included among the top collaborators of Xiaofei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Li. Xiaofei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Jiazhen, Xiaofei Li, Wenbo Chen, et al.. (2025). Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2. Redox Biology. 86. 103796–103796. 2 indexed citations
2.
Wu, Huimin, Zhiwen Lu, Zengyan Zhang, et al.. (2025). dPAFS: A nuclease-dead PfAgo-mediated fluorescence sensing platform for genotyping genome-edited rice. Biosensors and Bioelectronics. 278. 117364–117364. 2 indexed citations
3.
Li, Xiaofei, et al.. (2025). Tyrosine phosphatase SHP2 accelerated ovarian cancer via modulating integrin/ E-Cadherin/ ZEB1 induced EMT. Scientific Reports. 15(1). 1535–1535. 1 indexed citations
4.
Liu, Shuai, Liyuan Wang, Peng‐Fei Xu, et al.. (2025). Simultaneous profiling of ac4C and m5C modifications from nanopore direct RNA sequencing. International Journal of Biological Macromolecules. 305(Pt 1). 140863–140863. 3 indexed citations
5.
6.
Chen, Sixian, Xiaodong Zhou, Haotian Xu, et al.. (2025). NSUN2-mediated m5C modification of circFAM190B promotes lung cancer progression by inhibiting cellular autophagy. International Journal of Biological Macromolecules. 306(Pt 3). 141528–141528. 5 indexed citations
7.
Li, Xiaofei, et al.. (2025). Chemotherapy boosts anti-angiogenic and anti-PD-1 combination therapy through activation of cCAS-STING pathway in colon cancer. International Immunopharmacology. 149. 114212–114212. 1 indexed citations
8.
Liu, Yakun, et al.. (2023). Loss of the Novel Mitochondrial Membrane Protein FAM210B Is Associated with Hepatocellular Carcinoma. Biomedicines. 11(4). 1232–1232. 2 indexed citations
9.
Li, Deyuan, Lijun Wang, Xiaofei Li, et al.. (2023). circELMOD3 increases and stabilizes TRIM13 by sponging miR-6864-5p and direct binding to inhibit HCC progression. iScience. 26(10). 107818–107818. 3 indexed citations
10.
Guo, Lianyi, et al.. (2022). Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 3 indexed citations
11.
Xu, Haotian, Ruirui Zhang, Xin Wang, et al.. (2022). Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA. Molecular Therapy — Oncolytics. 24. 742–754. 11 indexed citations
12.
Li, Meiyu, et al.. (2022). IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS‐ERK Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 6570879–6570879. 10 indexed citations
13.
Wei, Bin, Lingyan Xu, Wenjie Guo, et al.. (2021). SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS–STING Activation and Chemotherapeutic Sensitivity in Colon Cancer. Cancer Research. 81(12). 3215–3228. 65 indexed citations
14.
Yang, Jialei, Haotian Xu, Xin Wang, et al.. (2021). Circular RNA circGLIS3 promotes bladder cancer proliferation via the miR-1273f/SKP1/Cyclin D1 axis. Cell Biology and Toxicology. 38(1). 129–146. 27 indexed citations
15.
Li, Xiaofei, Yuan Zhang, Cheng Fu, Yang Yu, & Deqing Wang. (2020). Metabolomics and Proteomics Reveal the Variation of Substances in Apheresis Platelets during Storage and Their Effects on Cancer Cell Proliferation. Transfusion Medicine and Hemotherapy. 48(2). 79–90. 2 indexed citations
16.
Zhang, Min, Jiuming He, Tiegang Li, et al.. (2019). Accurate Classification of Non-small Cell Lung Cancer (NSCLC) Pathology and Mapping of EGFR Mutation Spatial Distribution by Ambient Mass Spectrometry Imaging. Frontiers in Oncology. 9. 804–804. 28 indexed citations
17.
Zheng, Fufu, et al.. (2017). The effect of TMEFF2 methylation on the tumor stage and survival outcome of clear cell renal cell carcinoma. Cancer Biomarkers. 19(2). 207–212. 6 indexed citations
18.
Zheng, Fufu, et al.. (2017). Methylation of STK11 promoter is a risk factor for tumor stage and survival in clear cell renal cell carcinoma. Oncology Letters. 14(3). 3065–3070. 8 indexed citations
19.
20.
Xu, Lin, Zhu Wang, Shanyang He, et al.. (2016). Bax-interacting factor-1 inhibits cell proliferation and promotes apoptosis in prostate cancer cells. Oncology Reports. 36(6). 3513–3521. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaoyue Su Breakdown of academic impact, for papers by Mingdong Lu Breakdown of academic impact, for papers by Zhifeng Ning Breakdown of academic impact, for papers by Huayi Li Breakdown of academic impact, for papers by Jingyuan Sun Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by Chiara Ciardiello Breakdown of academic impact, for papers by Mohsen Karami Fath Breakdown of academic impact, for papers by Qinghui Zheng
Rankless by CCL
2026